Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cellivery Therapeutics, Inc.

Clinical trials sponsored by Cellivery Therapeutics, Inc., explained in plain language.

First human test of new inflammation blocker halted early

Knowledge-focused Terminated

This was the first-ever study in people for a new experimental drug called iCP-NI, designed to block inflammation. The main goal was to check if the drug was safe and how the body processes it in 24 healthy volunteers. The study was terminated early, and no results on how well it…

Phase: PHASE1 • Sponsor: Cellivery Therapeutics, Inc. • Aim: Knowledge-focused

Last updated Apr 04, 2026 09:21 UTC